Loading the security page…
A security analysis is not yet prepared for this market.
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 30 June 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Lucid Diagnostics Inc. (LUCD) is a company in the Health care sector; its shares trade on Nasdaq.
The price of Lucid Diagnostics Inc. (LUCD) on November 13, 2026 is $0.4491, +7.96% on the day. Over 52 weeks the stock traded between $0.3030 and $1.63; the price now sits 11% of the way up that range. Over the past year the price changed by −58.03%. Market capitalisation is $24.81 million, rank 80 among 101 stocks of the same industry with a known capitalisation.
Lucid Diagnostics Inc. trades on Nasdaq under the ticker LUCD. The company belongs to the Health care sector. The trading history on this page starts on 14 October 2021.
Over the past 52 weeks LUCD has traded between $0.3030 and $1.63. As of 13 November 2026 the price stood 11.02% of the way from the 52-week low to the high.
Over one year LUCD shares fell 58.03%; over six months they fell 54.68%. Volatility over 90 days is 104.84%. Dividends are not included: this is price change only, as of 13 November 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 4.6, above the sector median of 3.7. Price to book is 2.3, below the sector median of 2.3. Calculated from reports for the period ending 30 June 2026.
Lucid Diagnostics Inc. reported revenue of $5M and a net loss of $52M over the last four quarters. Net margin is −959.76%. Revenue changed by +24.89% year over year. Earnings per share are −$0.77. Market capitalisation is $25M.
LUCD has a return on equity of −478.26%, below the sector median of −40.58%. Return on assets is −134.18%, below the sector median of −30.08%. Operating margin is −930.82%, below the sector median of −20.96%.